Banco Santander S.A. trimmed its stake in shares of CME Group Inc. (NASDAQ:CME – Get Rating) by 3.3% in the 1st quarter, HoldingsChannel.com reports. The fund owned 48,758 shares of the financial services provider’s stock after selling 1,687 shares during the period. Banco Santander S.A.’s holdings in CME Group were worth $11,598,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently bought and sold shares of CME. Bromfield Sneider Wealth Advisors purchased a new stake in shares of CME Group during the 1st quarter worth approximately $26,000. IndexIQ Advisors LLC purchased a new stake in shares of CME Group during the 1st quarter worth approximately $27,000. Cornerstone Advisory LLC purchased a new stake in shares of CME Group during the 4th quarter worth approximately $29,000. Quent Capital LLC purchased a new stake in shares of CME Group during the 4th quarter worth approximately $38,000. Finally, St. James Investment Advisors LLC purchased a new stake in shares of CME Group during the 4th quarter worth approximately $42,000. 86.71% of the stock is currently owned by institutional investors.
CME Group Stock Performance
CME stock opened at $202.15 on Friday. CME Group Inc. has a twelve month low of $185.79 and a twelve month high of $256.94. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. The business’s fifty day simple moving average is $202.69 and its two-hundred day simple moving average is $219.59. The firm has a market cap of $72.66 billion, a price-to-earnings ratio of 25.08, a PEG ratio of 3.22 and a beta of 0.40.
CME Group Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 27th. Stockholders of record on Friday, September 9th will be given a dividend of $1.00 per share. This represents a $4.00 dividend on an annualized basis and a dividend yield of 1.98%. The ex-dividend date is Thursday, September 8th. CME Group’s payout ratio is 49.63%.
Analyst Upgrades and Downgrades
Several brokerages have recently issued reports on CME. Raymond James decreased their price objective on CME Group from $254.00 to $235.00 and set an “outperform” rating on the stock in a report on Wednesday, July 6th. Citigroup increased their price target on CME Group from $275.00 to $280.00 in a report on Thursday, April 28th. Argus upgraded CME Group from a “hold” rating to a “buy” rating in a report on Monday, May 16th. Atlantic Securities upgraded CME Group from a “neutral” rating to an “overweight” rating and set a $235.00 price target on the stock in a report on Friday, June 10th. Finally, Jefferies Financial Group started coverage on CME Group in a report on Tuesday, May 31st. They set a “buy” rating and a $267.00 price target on the stock. One analyst has rated the stock with a sell rating, nine have issued a hold rating and seven have given a buy rating to the company. According to MarketBeat, CME Group presently has an average rating of “Hold” and an average price target of $237.67.
CME Group Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products.
- Get a free copy of the StockNews.com research report on CME Group (CME)
- MarketBeat: Week in Review 8/1 – 8/5
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Cronos Group Inc’s Revenues Are Up, Is It Time to Buy?
- Beyond Meat Is Not Beyond Hope, And It’s Cheap
- Why Apple Could Be At All-Time Highs By Year End
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.